Table 1.
Phase 1 | Screened cases N = 42,765 | Positive cases N = 7,776 (18.18%) | P-value | |
---|---|---|---|---|
Nationality | =0 | |||
Saudi (%) | 11,724 (27.41%) | 1,847 (23.75%) | ||
Non-Saudi (%) | 31,041(72.59%) | 5,929 (76.25%) | ||
Gender | =0.0002 | |||
Male (%) | 35,979(84.13%) | 6,649 (85.51%) | ||
Female (%) | 6,786 (15.87%) | 1,127 (14.49%) | ||
Age (years) | =0 | |||
<1 | 230 (0. 54%) | 47 (0.6%) | ||
01–14 | 2,345 (5.48%) | 603 (7.75%) | ||
14–19 | 942 (2.2%) | 226 (2.91%) | ||
20–24 | 3,541 (8.28%) | 509 (6.55%) | ||
25–29 | 7,904 (18.48%) | 1,267 (16.29%) | ||
30–39 | 15,822 (36.95%) | 2,717 (34.94%) | ||
40–49 | 8,051 (18.83%) | 1,543 (19.84%) | ||
50–59 | 3,108 (7.27%) | 675 (8.68%) | ||
60–69 | 635 (1.48%) | 155 (1.99%) | ||
70+ | 172 (0.4%) | 33 (0.42%) | ||
Phase 2 | Screened Cases N = 29, 089 | Positive Cases N = 1,925 (6.62%) | ||
Nationality | =0 | |||
Saudi (%) | 20,368 (70.02%) | 1,018 (52,88%) | ||
Non-Saudi (%) | 8,721 (29.98%) | 907 (47.12%) | ||
Gender | =0 | |||
Male (%) | 23,856 (82.01%) | 1,504 (78.13%) | ||
Female (%) | 5,233 (17.99%) | 421 (21.87%) | ||
Age (years) | =0 | |||
<1 | 99 (0.34%) | 9 (0.47%) | ||
01–14 | 1,305 (4.49%) | 150 (7.79%) | ||
14–19 | 1,023 (3.52%) | 63 (3.27%) | ||
20–24 | 2,954 (10.16%) | 176 (9.14%) | ||
25–29 | 5,213 (17.92%) | 319 (16.57%) | ||
30–39 | 11,178 (38.43%) | 638 (33.14%) | ||
40–49 | 4,807 (16.53%) | 339 (17.61%) | ||
50–59 | 1,803 (6.20%) | 174 (9.04%) | ||
60–69 | 524 (1.8%) | 43 (2.23%) | ||
70+ | 177 (0.61%) | 13 (0.68%) |